Mobile App of CBT for Anxiety and Cancer

Completed · Not applicable

Conditions studied: Cancer, Anxiety

In brief

The proposed study seeks to implement a randomized controlled trial to evaluate the effectiveness and generalizability of an efficacious cognitive-behavioral therapy (CBT) intervention for use as a self-administered mobile application (mobile app) to treat anxiety in patients with metastatic cancer.

Key facts

Study ID

NCT02286466

Run by

Massachusetts General Hospital

People needed

145

Starts

2015-02-18

Expected to finish

2016-10-25

Last updated by the study team

2018-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of a metastatic solid tumor
• Report clinically significant anxiety symptoms (i.e., Hospital Anxiety and Depression Scale (HADS) -Anxiety Subscale > or equal to 8)
• Anxiety is principal psychiatric problem
• At least four weeks after cancer diagnosis
• Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
• Age greater than 18 years
• Ability to read and respond to questions in English

You may not qualify if…

• Co-morbid delirium, dementia, or active and untreated major psychiatric condition such as schizophrenia will be excluded from the study

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.